<DOC>
	<DOCNO>NCT00571142</DOCNO>
	<brief_summary>To Evaluate combined effect vitrectomy bevacizumab stabilize retinal thickness visual acuity patient diffuse diabetic macular edema relation renal disease .</brief_summary>
	<brief_title>Vitrectomy Bevacizumab Diffuse Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Older 25 yo Diffuse diabetic macular edema without previous treatment Another retinal disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>edema</keyword>
	<keyword>retinal thickness</keyword>
	<keyword>diabetic retinopathy</keyword>
</DOC>